Dashboard
Faculty
Programme
Login
Dashboard
Faculty
Programme
Login
Disruptive Technologies in Transplantation
Monday September 14, 2020 from 17:45 to 19:30
Room: Channel 1
300.3 Reducing risk in drug development through precompetitive collaboration
Log in to add to favorites
Add Personal Notes
Inish O'Doherty, United States
Executive Director
C-Path’s Type 1 Diabetes (T1D) and Transplant Therapeutic Consortium (TTC)
Critical Path Institute
Presentations by Inish O'Doherty
Mon-14 from 17:45 - 19:30 in room Channel 1
Disruptive Technologies in Transplantation
Reducing risk in drug development through precompetitive collaboration
Tue-15 from 01:45 - 03:30 in room Channel 1
Disruptive Technologies in Transplantation (Repeat)
Reducing risk in drug development through precompetitive collaboration
Tue-15 from 08:45 - 10:30 in room Channel 1
Disruptive Technologies in Transplantation (Repeat)
Reducing risk in drug development through precompetitive collaboration
Tue-15 from 19:30 - 20:00 in room Networking 3
Interview and Q&A with Plenary Speakers Alan Ashworth and Inish O'Doherty
-
Email:
info@virtual.tts.org
+1.514.874-1717
© 2024 TTS 2020
